Stop semaglutide and contact your healthcare provider to rule out diverticulitis recurrence or bowel obstruction
59,60 GLP-1RAs reduce epicardial fat, which is known to play a key role in triggering atrial remodelling in obesity
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
The relationship between semaglutide and sexual health is likely indirect and multifactorial rather than a direct drug effect
Weight, shots, side effects, and food live on the same timeline in the same free app, which is what makes the pattern visible - and what makes the record worth showing at an appointment
Ron Grisanti, D.C., D.A.B.C.O., D.A.C.B.N., M.S., DIANM, CFMP Founder, Functional Medicine University Medical & Educational Disclaimer : The information provided is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment